Additionally, K-RAS mutations are also involved in the suppression of innate and adaptive anti-tumor immunity through modulating PDAC expressions of immune checkpoints such as PD-L1 and CD47 (32, 33), as well as through autophagy-mediated MHC-I downregulation in PDAC (34, 35). Here, CD274 is linked to neoplasm.